Karavanskaya I. Clinico-immunologic estimation of Korvitine efficacy usage in the patients with acute myocardial infarction

Thesis Registration Form

0404U004196.pdf

aref.doc

Диссертация.doc

С 106. Табл. 5.1.1.doc

С 107. Рис. 5.1.1.doc

С 110. Табл. 5.1.2 .doc

С 111. Табл. 5.1.3.doc

С 113. Рис. 5.1.3.doc

С 115. Рис. 5.1.4.doc

С 117. Табл. 5.2.1.doc

С 119. Табл. 5.2.2.doc

С 120. Табл. 5.2.3.doc

С 124. Рис. 5.3.1.doc

С 127. Табл. 5.4.1.doc

С 130. Табл. 5.4.3.doc

С 131. Табл. 5.4.4.doc

С 132. Табл. 5.4.5.doc

С 133. Табл. 5.4.6.doc

С 140. Рис. 6.1.1.doc

С 142. Рис. 6.1.2.doc

С 145. Рис. 6.1.3.doc

С 147. Рис. 6.1.4.doc

С 150. Рис. 6.2.1.doc

С 152. Табл. 6.2.2.doc

С 52. Табл. 3.1.2 .doc

С 88. Рис. 4.2.4.doc

С 89. Рис. 4.2.6.doc

С 90. Рис. 4.2.7.doc

С 94. Табл. 4.3.1 .doc

С 98. Табл. 4.4.1.doc

С 99. Табл. 4.4.2.doc

0524U000129

Oksana L. Rekovets

Сlinical and pathogenetic justification of individual diagnostic approaches and treatment programs in resistant arterial hypertension

0523U100016

Maslovskyi Valentyn Iuriyovych

Prognostic value of various clinical and instrumental markers and options for basic therapy to assess the quality of life and the nature of the course of myocardial infarction without elevation of the ST segment

0421U103208

Kovbasniuk Yuriy Vasylovych

Structure and functional myocardial changes and features of plasma hemostasis by patient with atrial fibrillation and different body mass index

0821U101742

Tanska Olha Oleksandrivna

Criteria for Patients to be Put on the Waiting List for Heart Transplantation

0821U101115

Kutia Inna Mykolaivna

Pathogenetic and prognostic value of vascular endothelial growth factor-A in acute myocardial infarction with the ST segment elevation